California Gov. Gavin Newsom announced on Oct. 16 that the state would start selling its own brand of affordable insulin pens next year to improve access to essential medication across the state.
The insulin pens will be sold under the state’s CalRx brand for $11 per pen or $55 per five-pack, with sales expected to begin on Jan. 1, 2026, according to a statement from the governor’s office.





